LINKER-BASED LECITHIN MICROEMULSIONS FOR TRANSDERMAL DELIVERY OF LIDOCAINE.
This study by researchers at the University of Toronto demonstrated that MatTek’s EpiDerm in vitro human skin tissue equivalent is an excellent in vitro alternative for examining the transdermal permeation and cytotoxicity characteristics of novel microemulsions. In this work, researchers at the University of Toronto introduce alcohol-free lecithin microemulsions formulated with linkers to produce transdermal delivery vehicles. The food-grade linker system consists of a combination of sodium caprylate and caprylic acid (hydrophilic linkers), and sorbitan monooleate (lipophilic linker). A “carrier” oil (isopropyl myristate) was used to pre-dissolve a model lipophilic drug, lidocaine. The first part of the article describes the phase behavior and physical properties of these linker-based lecithin microemulsions. In the second part of the article, we evaluate the transdermal permeation and cytotoxicity of lidocaine formulated in oil-in-water (Type I), water-in-oil (Type II), and bi-continuous linker microemulsions. The transdermal permeation studies show that compared to a conventional Type II alcohol-based lecithin micro-emulsion, Type II linker-based microemulsions provide twice the absorption and penetration of lidocaine through skin. The larger flux obtained with linker systems is due to the presence of sodium caprylate and caprylic acid. These hydrophilic linkers accelerate the microemulsion-skin mass transfer by reducing the interfacial rigidity of the systems. Furthermore, the cytotoxicity studies show that these linker microemulsions are significantly less toxic than the alcohol-based system. The Type II linker microemulsion (containing approximately 4% lidocaine) has a comparable cytotoxicity to water saturated with lidocaine (0.4% lidocaine).
Bicontinuous linker microemulsions, EPI-200, EpiDerm, Lecithin microemulsions, Oil in water emulsion, Transdermal delivery, Transdermal drug delivery, Transdermal permeation, Water in oil emulsion
Lidocaine
Request a copy of this paper, click here.